Anti-FAM163B monoclonal antibody

Pre-made anti-FAM163B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAM163B/FAM163B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0802-Ab-1/ GM-Tg-hg-IP0802-Ab-2Anti-Human FAM163B monoclonal antibodyHuman
GM-Tg-rg-IP0802-Ab-1/ GM-Tg-rg-IP0802-Ab-2Anti-Rat FAM163B monoclonal antibodyRat
GM-Tg-mg-IP0802-Ab-1/ GM-Tg-mg-IP0802-Ab-2Anti-Mouse FAM163B monoclonal antibodyMouse
GM-Tg-cynog-IP0802-Ab-1/ GM-Tg-cynog-IP0802-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM163B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0802-Ab-1/ GM-Tg-felg-IP0802-Ab-2Anti-Feline FAM163B monoclonal antibodyFeline
GM-Tg-cang-IP0802-Ab-1/ GM-Tg-cang-IP0802-Ab-2Anti-Canine FAM163B monoclonal antibodyCanine
GM-Tg-bovg-IP0802-Ab-1/ GM-Tg-bovg-IP0802-Ab-2Anti-Bovine FAM163B monoclonal antibodyBovine
GM-Tg-equg-IP0802-Ab-1/ GM-Tg-equg-IP0802-Ab-2Anti-Equine FAM163B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0802-Ab-1/ GM-Tg-hg-IP0802-Ab-2; GM-Tg-rg-IP0802-Ab-1/ GM-Tg-rg-IP0802-Ab-2;
GM-Tg-mg-IP0802-Ab-1/ GM-Tg-mg-IP0802-Ab-2; GM-Tg-cynog-IP0802-Ab-1/ GM-Tg-cynog-IP0802-Ab-2;
GM-Tg-felg-IP0802-Ab-1/ GM-Tg-felg-IP0802-Ab-2; GM-Tg-cang-IP0802-Ab-1/ GM-Tg-cang-IP0802-Ab-2;
GM-Tg-bovg-IP0802-Ab-1/ GM-Tg-bovg-IP0802-Ab-2; GM-Tg-equg-IP0802-Ab-1/ GM-Tg-equg-IP0802-Ab-2
Products NameAnti-FAM163B monoclonal antibody
Formatmab
Target NameFAM163B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAM163B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0802-Ag-1Recombinant multi-species F163B/ FAM163B/ C9orf166 protein


    Target information

    Target IDGM-IP0802
    Target NameFAM163B
    Gene ID642968,109349,685169,722179,100855739,101083218,615192,100147292
    Gene Symbol and SynonymsC630035N08Rik,C9orf166,FAM163B
    Uniprot AccessionP0C2L3
    Uniprot Entry NameF163B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000196990
    Target ClassificationN/A

    The target: FAM163B, gene name: FAM163B, also named as C9orf166. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.